Scout | FDA renewal to support Critical Path Institute consortia advancing drug development

This opportunity is no longer accepting applications.

grant

FDA renewal to support Critical Path Institute consortia advancing drug development

The FDA is seeking an application to renew a cooperative agreement with the Critical Path Institute to maintain and manage existing consortia. Funding will back collaborative projects in research, education, and outreach to accelerate drug development, manufacturing, and translational therapeutics, improving safety, efficacy, quality, and performance. Awards are subject to available FDA funds.…

Source

Agency: Food and Drug Administration

Award

Award Ceiling: $20M

Award Floor: $20M

Eligibility

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Keywords

fda

cooperative agreement

critical path institute

public-private partnership

drug development

clinical trials

research consortia

translational therapeutics

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers